155 related articles for article (PubMed ID: 7026250)
21. Oral hydralazine therapy for primary pulmonary hypertension.
Rubin LJ; Peter RH
N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic effects of nifedipine in congestive heart failure.
Matsumoto S; Ito T; Sada T; Takahashi M; Su KM; Ueda A; Okabe F; Sato M; Sekine I; Ito Y
Am J Cardiol; 1980 Sep; 46(3):476-80. PubMed ID: 7415993
[TBL] [Abstract][Full Text] [Related]
23. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
[TBL] [Abstract][Full Text] [Related]
24. Hydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses.
Magorien RD; Unverferth DV; Leier CV
Am J Med; 1984 Aug; 77(2):267-74. PubMed ID: 6431812
[TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure.
Mathey D; Hanrath P; Polster J; Witte G; Montz R; Bleifeld W
Eur Heart J; 1980 Feb; 1(1):25-9. PubMed ID: 7285964
[No Abstract] [Full Text] [Related]
26. Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.
Figueras J; Taylor WR; Ogawa T; Forrester JS; Singh BN; Swan HJ
Br Heart J; 1979 Mar; 41(3):317-24. PubMed ID: 371647
[No Abstract] [Full Text] [Related]
27. [Hemodynamic effects of hydralazine at rest and during exercise, in patients with congestive heart failure (author's transl)].
Lanas F; Salvatici R; Opazo JA; Stockins B; Saavedra J; Schulthess L
Rev Med Chil; 1980 Jul; 108(7):599-604. PubMed ID: 7209179
[No Abstract] [Full Text] [Related]
28. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure.
Quyyumi AA; Wagstaff D; Evans TR
Am J Cardiol; 1983 May; 51(8):1353-7. PubMed ID: 6846162
[TBL] [Abstract][Full Text] [Related]
29. Precipitation of heart failure following sudden withdrawal of hydralazine.
Black JR; Mehta J
Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
Groves BM; Rubin LJ; Frosolono MF; Cato AE; Reeves JT
Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
[TBL] [Abstract][Full Text] [Related]
31. Hydralazine in chronic CHF.
Chatterjee K; Rouleau JL; Massie BM
Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
Rubin LJ; Peter RH
Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.
Jafri SM; Burlew BS; Goldberg AD; Rogers A; Goldstein S
Am J Cardiol; 1986 Feb; 57(4):254-9. PubMed ID: 3511661
[TBL] [Abstract][Full Text] [Related]
34. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
Rubin LJ; Handel F; Peter RH
Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
[TBL] [Abstract][Full Text] [Related]
35. Beneficial hemodynamic effects of intravenous diazoxide in refractory congestive heart failure.
Massie BM; Stern R; Hanlon JT; Haughom F
Am Heart J; 1982 Sep; 104(3):581-6. PubMed ID: 7113899
[TBL] [Abstract][Full Text] [Related]
36. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
[No Abstract] [Full Text] [Related]
37. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
Timmis AD; Richardson PJ
Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
[No Abstract] [Full Text] [Related]
38. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure.
Elkayam U; Weber L; Campese VM; Massry SG; Rahimtoola SH
J Am Coll Cardiol; 1984 Dec; 4(6):1261-7. PubMed ID: 6501724
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
[TBL] [Abstract][Full Text] [Related]
40. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
